Receptor pharmacology and other relevant factors in lower urinary tract pathology under a functional and toxicological approach: Instrument to better manage antimicrobials therapy

Main Article Content

Mauro Luisetto
Naseer Almukhtar
Behzad Nili-Ahmadabadi
Ghulam Rasool Mashori
Kausar Rehman Khan
Ram Kumar Sahu
Farhan Ahmad Khan
Gamal Abdul Hamid
Luca Cabianca

Abstract

In various patients conditions involved in lower urinary tract disease LUT (like overactive bladder, bladder neck sclerosis, dis –synergy (with our synenrgic contraction between bladder detrusor and bladder neck, BPH, recurrent cysytitis, interstitial cystitis, chronic prostatitis, uretral stenosys, loss of sfinteric coordination.


Prostatic cancer, anatomic abnormalities and other the receptor status play relevant role to reduce effect of vicious clycle that can be responsible in progression of the pathologic process.


In this work the complex receptorial status is analyzed to verify new therapeutic strategies.


Starting from the observation that various irritant substanties produce irritant stimulus in Prostatic Patients or in bladder neck condition is interesting to deep understand the etio-patogenesys and Functional results.


In Various prostatic, bladder neck or ureteral condition a reduced urinary fluss can produce infectious.


Conditions like acute or chronic prostatitis.


Irritants sustanties in diet (in example etilic alcohol drink, hot spices, crud meats, carbonate drinks, caffeine and other) can produce Painful stimulus in innervations of vecical trigonous, bladder neck and prostatic urethra.


The same recurrent cystitis and Bph contribute in a complex situation.


This stimulus produce ipertonus of bladder muscle involved in the expulsion of urine.


The event related inflamation and edema (bladder, prostatic uretra, trigonus) contribute to the global effect.


So conditions like bladder neck sclerosys IPB, recurrent prostatitis and cistitys in acts in a vicious circle. (Also immunomediated: Bph and cronic prostatitis with linfocite infiltration and tissue remodeling).


The ormonal status check the systems (see 5-ARI efficacy in Bph).


Simpatic, parasimpatic and other system are deeply involved.


Also behavioral habits or diet can influence in example urinary flux in a complex system like LUT. (Bladder and prostatic irritants that can produce edema and acute inflamation).


Other behavior habits are deeply involved as too much sedentary, water intake, coffee, pee modality and also psychological profile and stressing conditions.


Some disease like diabetes produce high consequences in all this systems due to


Bladder modification, oxidative stress, osmotic movens, and increase susceptibility of urinary infections.


This article are verified this kind of movens that contribute in physio -pathology of some low urinary tract conditions.


The anatomic abnormalities produces, obviously, physiological disfuntions.


Recurrent urinary tract infections, inadequate antimicrobial therapy:


Profile of resistance, duration of therapy, kind of antimicrobials, posology,


Pk. Kinetics, associations, compliance, biofilms, micro calcifications (recurrent chronic prostatitis) contribute to a progression of the condition.

Article Details

Luisetto, M., Almukhtar, N., Nili-Ahmadabadi, B., Mashori, G. R., Khan, K. R., Sahu, R. K., … Cabianca, L. (2018). Receptor pharmacology and other relevant factors in lower urinary tract pathology under a functional and toxicological approach: Instrument to better manage antimicrobials therapy. Archives of Pathology and Clinical Research, 2(1), 049–093. https://doi.org/10.29328/journal.apcr.1001010
Research Articles

Copyright (c) 2018 Luisetto M, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Kogan P, Xu S, Wang Y, O'Donnell MA, Lutgendorf SK, et al. Sub-noxious Intravesical Lipopolysaccharide Triggers Bladder Inflammation and Symptom Onset in a Transgenic Autoimmune Cystitis Model: A MAPP Network Animal Study. Sci Rep. 2018; 8: 6573. Ref.: https://goo.gl/uc6w7B

Fiander N. Painful bladder syndrome and interstitial cystitis: treatment options. Br J Nurs. 2013; 22: S26, S28-33. Ref.: https://goo.gl/Wue6qf

Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009; 63: 1177-1191. Ref.: https://goo.gl/gce1LC

Kaddumi EG, Hubscher CH. Urinary bladder irritation alters efficacy of vagal stimulation on rostral medullary neurons in chronic T8 spinalized rats. J Neurotrauma. 2007; 24: 1219-1228. Ref.: https://goo.gl/L2kpQZ

Shorter B, Lesser M, Moldwin RM, Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007; 178: 145-152. Ref.: https://goo.gl/zM5Gbd

Ellenbroek JH, Arioglu Inan E, Michel MC. A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences. Neurourol Urodyn. 2018; 37: 2346-2360. Ref.: https://goo.gl/zLpvBQ

Tong YC, Chin WT, Cheng JT. Role of sorbitol in the up-regulation of urinary bladder M(2) muscarinic receptors in streptozotocin-induced diabetic rats. Neurourol Urodyn. 2002; 21: 154-159. Ref.: https://goo.gl/scNz9y

Liu BK, Jin XW, Lu HZ, Zhang X, Zhao ZH, Shao Y. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis. Inflammation. 2018; Ref.: https://goo.gl/gd9FwX

Butler DSC, Ambite I, Nagy K, Cafaro C, Ahmed A, et al. Neuroepithelial control of mucosal inflammation in acute cystitis. Sci Rep. 2018; 8: 11015. Ref.: https://goo.gl/pwf13G

Tourret J, Bagnis CI, Denamur E. [Urinary tract infections in diabetic patients]. Rev Prat. 2014; 64: 980-983. Ref.: https://goo.gl/qWFXRy

Ross MA. Neuropathies associated with diabetes. Med Clin North Am. 1993; 77: 111-124. Ref.: https://goo.gl/QzNBgL

Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013; 304: R84–R93. Ref.: https://goo.gl/26o3bQ

Birder L, de Groat W, Mills I, Morrison J, Thor K, et al. Neural Control of the Lower Urinary Tract: Peripheral and Spinal Mechanisms. Neurourol Urodyn. 2010; 29: 128–139. Ref.: https://goo.gl/zdoDU8

Thor KB, Katofiasc MA, Danuser H, Springer J, Schaus JM. The role of 5-HT(1A) receptors in control of lower urinary tract function in cats. Brain Res. 2002; 946: 290-297. Ref.: https://goo.gl/DWxnss

luisetto M, Nili-Ahmadabadi N, Mashori GR, Sahu RK, Khan FA, et al. Immunitary role in chronic prostatitis and growth factors as promoter of BPH. Insights Clin Cell Immunol. 2018; 2: 001-013. Ref.: https://goo.gl/qfA1RL

Luisetto M, Nili-Ahmadabadi B. Chronic Prostatitis: The Clinical Pharmacist Role and New Delivery Systems. J Bioanal Biomed 9:e151. Ref.: https://goo.gl/dnsWrA

Luisetto M, Behzad NA, Ghulam RM. Relapses and Recurrent Chronic Bacteric Prostatitis - Biofilm Related, A Case Report. J of Pharmacol & Clin Res. 2017; 4: 555644. Ref.: https://goo.gl/LkQzu8

Xue ZNK. Xu Z, Jia RP. [PDE5: A new therapeutic target for lower urinary tract symptoms/ benign prostatic hyperplasia combined with erectile dysfunction]. 2018; 24: 355-359. Ref.: https://goo.gl/88HQV9

Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med. 2015; 9: 658-666. Ref.: https://goo.gl/fRnfjJ

Ozaki T, Matsuoka J, Tsubota M, Tomita S, Sekiguchi F, et al. Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Cav3.2 in mice. Toxicology. 2018; 393: 102-112. Ref.: https://goo.gl/ixt1BZ

Lovick TA. Central control of visceral pain and urinary tract function. Auton Neurosci. 2016; 200: 35-42. Ref.: https://goo.gl/Lc1ugW

Tonon L, Fromont G, Boyault S, Thomas E, Ferrari A, et al. Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men. Eur Urol. 2018; pii: S0302-2838(18)30618-3. Ref.: https://goo.gl/qGUQRA

Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic Bladder Dysfunction: Current Translational Knowledge. J Urol. 2009; 182: S18–S26. Ref.: https://goo.gl/jU4zfF

Montalbetti N, Rued AC, Taiclet SN, Birder LA, Kullmann FA, et al. Urothelial Tight Junction Barrier Dysfunction Sensitizes Bladder Afferents. eNeuro. 2017; 4. pii: ENEURO.0381-16.2017. Ref.: https://goo.gl/HnQFRp

Nicholson HL, Al-Hakeem Y, Maldonado JJ, Tse V. Management of bladder neck stenosis and urethral stricture and stenosis following treatment for prostate cancer. Transl Androl Urol. 2017; 6(Suppl 2): S92–S102. Ref.: https://goo.gl/49P9tR

Zhao Z, Zhang J, He J, Zeng G. Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study. PLoS One. 2013; 8: e52044 Ref.: https://goo.gl/d8g6SE

Kim HJ, Moon H, Sohng I, Lee HW, Lee G, Lee JG. Effects of ethanol and its metabolite acetaldehyde on responses of the rat bladder. BJU Int. 1999; 83: 686-692. Ref.: https://goo.gl/VGsojr

Magistro G, Wagenlehner FM, Grabe M, Weidner W, Stief CG, et al. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Eur Urol. 2016; 69: 286-297 Ref.: https://goo.gl/QHExzx

Bayrak O, Erturhan S, Seckiner I, Erbagci A, Ustun A, et al. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder. Urol Ann. 2014; 6:122-126. Ref.: https://goo.gl/HJ7uiz

Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014; 2: 199–208. Ref.: https://goo.gl/V4F4ch

Golbidi S, Laher I. Bladder Dysfunction in Diabetes Mellitus. Front Pharmacol. 2010; 1: 136. Ref.: https://goo.gl/QMAUx5

Nitti VW. Primary Bladder Neck Obstruction in Men and Women. Rev Urol. 2005; 7(Suppl 8): S12–S17. Ref.: https://goo.gl/erKX5U

Chen C, Zeng M, Xue R, Wang G, Gao Z, et al. [Causes and management for male urethral stricture]. 2018; 43: 520-527. Ref.: https://goo.gl/q3ZRCw

van Rij S, Gilling P. Recent advances in treatment for Benign Prostatic Hyperplasia. Version 1. F1000Res. 2015; 4: F1000 1482. Ref.: https://goo.gl/Sg51ss

Khan RN, Zaidi SZ. Comparison of position-related changes on uroflowmetric parameters in healthy young men. J Pak Med Assoc. 2017; 67: 839-842. Ref.: https://goo.gl/MXjjWf

Gravas S, Samarinas M, Zacharouli K, Karatzas A, Tzortzis V, et al. The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study. World J Urol. 2018; Ref.: https://goo.gl/tjHXRF

Morelli A, Sarchielli E, Comeglio P, Filippi S, Mancina R, et al. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. J Sex Med. 2011; 8: 2746-2760. Ref.: https://goo.gl/7A6PYY

Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, et al. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med. 2010; 7(1 Pt 1): 59-69. Ref.: https://goo.gl/i5bhjC

Krivoborodov GG, Shumilo DV, Basil'ev AV, Tur EI, Poddubnaia NV. [Botulinic toxin type a in combined treatment of males with chronic pelvic pain syndrome in combination with bladder emptying dysfunction]. Urologiia. 2011; 5: 67-72. Ref.: https://goo.gl/frFzff

Zhanel GG, Zhanel MA, Karlowsky JA. Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli. Can J Infect Dis Med Microbiol. 2018; 2018: 1404813. Ref.: https://goo.gl/xxC1Jx

Niemitz C. The evolution of the upright posture and gait—a review and a new synthesis. Naturwissenschaften. 2010; 97: 241–263. Ref.: https://goo.gl/Z7DTSS

Kwon WA. Animal Model of Interstitial Cystitis/Bladder Pain Syndrome. Int Neurourol J. 2018 Jan; 22(Suppl 1): S1–2. Ref.: https://goo.gl/W2HYwx

Lusty A, Kavaler E, Zakariasen K, Tolls V, Nickel JC. Treatment effectiveness in interstitial cystitis/bladder pain syndrome: Do patient perceptions align with efficacy-based guidelines? Can Urol Assoc J. 2018; 12: E1–E5. Ref.: https://goo.gl/2kvp2u

Cvach K, Rosamilia A. Review of intravesical therapies for bladder pain syndrome/interstitial cystitis. Transl Androl Urol. 2015; 4: 629–637. Ref.: https://goo.gl/edK5Zi

Jayasimha S. Nanotechnology in Urology. Indian J Urol. 2017; 33: 13–18. Ref.: https://goo.gl/Z4YvXC

Zacchè MM, Srikrishna S, Cardozo L. Novel targeted bladder drug-delivery systems: a review. Res Rep Urol. 2015; 7: 169–178. Ref.: https://goo.gl/NeCvih

Goel A, Kanodia G, Sokhal AK, Singh K, Agrawal M. et al. Evaluation of Impact of Voiding Posture on Uroflowmetry Parameters in Men. World J Mens Health 2017; 35: 100-106. Ref.: https://goo.gl/cGRi3f

Ngai HY, Yuen KKS, Ng CM, Cheng CH, Chub SKP. Metabolic syndrome and benign prostatic hyperplasia: An update. Asian J Urol. 2017; 4: 164–173. Ref.: https://goo.gl/goe5c8

Lee CL, Kuo HC. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts. Ci Ji Yi Xue Za Zhi. 2017; 29: 79–83. Ref.: https://goo.gl/UaeCZX

Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017; 129: 242-258. Ref.: https://goo.gl/9PpL1t

Huang Z, Xiao H, Li H, Yan W, Ji Z. Analysis of the incidence and risk factors of male urinary tract infection following urodynamic study. Eur J Clin Microbiol Infect Dis. 2017; 36: 1873-1878. Ref.: https://goo.gl/FUkZkP

Singh AV, Hosseinidoust Z, Park BW, Yasa O, Sitti M. Microemulsion-Based Soft Bacteria-Driven Microswimmers for Active Cargo Delivery. ACS Nano. 2017; 11: 9759-9769. Ref.: https://goo.gl/Ys9G62

Singh AV, Khare M, Gade WN, Zamboni P. Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. Autoimmune Diseases. 2012; 2012, Article ID 160830: 12. Ref.: https://goo.gl/H9xkyN

Singh AV, Vyas V, Salve TS, Cortelli D, Dellasega D, et al. Biofilm formation on nanostructured titanium oxide surfaces and a micro/nanofabrication-based preventive strategy using colloidal lithography. Biofabrication. 2012; 4: 025001. Ref.: https://goo.gl/STBBWv